Structures by: Nehls I.
Total: 15
Deacetyl tenuazonic acid
C8H13NO2
Acta Crystallographica Section E (2009) 65, 6 o1201
a=5.0114(4)Å b=7.7961(4)Å c=10.9919(10)Å
α=90.00° β=95.778(4)° γ=90.00°
Deacetyl tenuazonic acid <i>p</i>-toluenesulfonylhydrazone
C15H21N3O3S
Acta Crystallographica Section E (2009) 65, 12 o3136
a=5.1286(16)Å b=8.285(3)Å c=38.430(12)Å
α=90.00° β=90.00° γ=90.00°
Alternariol
C14H10O5
Acta Crystallographica Section E (2010) 66, 6 o1366
a=18.969(3)Å b=3.7244(6)Å c=15.235(3)Å
α=90.00° β=90.00° γ=90.00°
Methyl 3,5,5,6,8,8-hexamethyl-5,6,7,8-tetrahydronaphthalene-2-carboxylate
C18H26O2
Acta Crystallographica Section E (2011) 67, 2 o485
a=11.5049(11)Å b=11.9482(5)Å c=12.1078(13)Å
α=90.00° β=102.612(5)° γ=90.00°
3,5,5,6,8,8-Hexamethyl-5,6,7,8-tetrahydro-2-naphthoic acid
C17H24O2
Acta Crystallographica Section E (2010) 66, 10 o2687
a=8.9718(2)Å b=10.1447(3)Å c=17.7058(5)Å
α=90.00° β=112.3100(19)° γ=90.00°
Tenuazonic acid 2,4-dinitrophenylhydrazone
C16H19N5O6
Acta Crystallographica Section E (2009) 65, 5 o988-o989
a=10.6710(10)Å b=4.9387(5)Å c=16.839(2)Å
α=90.00° β=107.363(4)° γ=90.00°
(6a<i>R</i>,9<i>S</i>)-<i>N</i>-[(<i>S</i>)-1-hydroxypropan-2-yl]-7-methyl- 4,6,6a,7,8,9-hexahydroindolo[4,3-<i>fg</i>]quinoline-9-carboxamide
C19H23N3O2
Acta Crystallographica Section E (2010) 66, 9 o2275
a=7.4097(5)Å b=12.7313(7)Å c=18.2648(9)Å
α=90.00° β=90.00° γ=90.00°
<i>rac</i>-(1<i>R</i>,2<i>R</i>,4<i>S</i>)-1,2-Dibromo-4-[(1<i>R</i>)-1,2- dibromoethyl]cyclohexane
C8H12Br4
Acta Crystallographica Section E (2010) 66, 12 o3318
a=9.6163(14)Å b=13.9193(19)Å c=9.6354(15)Å
α=90.00° β=111.769(9)° γ=90.00°
(3,5,5,6,8,8-Hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)methanol
C17H26O
Acta Crystallographica Section E (2011) 67, 6 o1462-o1463
a=17.6364(7)Å b=29.0183(15)Å c=11.6701(5)Å
α=90.00° β=90.00° γ=90.00°
Lysergol monohydrate
C16H18N2O,H2O
Acta Crystallographica Section E (2012) 68, 2 o523
a=7.6234(12)Å b=12.3803(19)Å c=15.877(2)Å
α=90.00° β=90.00° γ=90.00°
N-(β-Carboxyethyl)-α-isoleucine
C9H18N2O3
Acta Crystallographica Section E (2013) 69, 2 o172-o173
a=5.2989(17)Å b=9.024(3)Å c=23.268(7)Å
α=90.00° β=90.00° γ=90.00°
Isopropyl 2,3,4,6-tetra-<i>O</i>-acetyl-β-<i>D</i>-glucopyranoside
C17H26O10
Acta Crystallographica Section E (2013) 69, 2 o157
a=9.4225(12)Å b=9.9313(12)Å c=11.3641(15)Å
α=90.00° β=98.482(9)° γ=90.00°
<i>n</i>-Propyl 2,3,4,6-tetra-<i>O</i>-acetyl-β-<i>D</i>-glucopyranoside
C17H26O10
Acta Crystallographica Section E (2013) 69, 2 o158
a=7.0072(11)Å b=15.215(3)Å c=19.579(3)Å
α=90.00° β=90.00° γ=90.00°
Ergotaminine
C33H35N5O5
Acta Crystallographica Section E (2012) 68, 3 o610-o611
a=10.974(3)Å b=9.662(2)Å c=14.450(4)Å
α=90.00° β=105.059(15)° γ=90.00°
1-(4-Bromo-3,5,5,6,8,8-hexamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethan-1-one
C18H25BrO
Acta Crystallographica Section E (2013) 69, 4 o545
a=35.007(8)Å b=19.760(5)Å c=24.826(10)Å
α=90.00° β=127.681(6)° γ=90.00°